The Right Amount of Medicine: DGIM Releases Five New “Smart Decisions” Recommendations
Introduction to the Need for “Smart Decisions”
The balance of medical care is crucial—knowing when to act and when to hold back is a key challenge. The German Society for Internal Medicine (DGIM) has recognized this need through its “Smart Decisions” initiative, unveiling five new recommendations that tackle over- and under-treatment issues. This set of guidelines specifically addresses conditions found in gastroenterology and cardiology. Key topics include irritable bowel syndrome, malnutrition, and exercise therapy for cardiovascular diseases.
The Importance of Appropriate Medical Care
Medical over-treatment and under-treatment are dual aspects of healthcare that can lead to significant patient risks. While some effective treatments are underutilized, patients often undergo unnecessary procedures that may not help their conditions. As Professor Dr. Sebastian M. Schellong notes, the “Smart Decisions” initiative is designed to address these concerns through concrete, evidence-based recommendations.
Understanding the Scope of “Smart Decisions”
Since 2015, the DGIM’s “Smart Decisions” initiative has cultivated a wealth of guidelines aimed at enhancing the quality of internal medicine. Nearly 200 recommendations were published from 2016 to 2024, with 165 currently classified as valid. The latest additions, which debuted at the DGIM Congress in April 2026, further emphasize the initiative’s commitment to ensuring quality and effective healthcare.
Overview of the New Recommendations
1. Early Detection and Treatment of Malnutrition in Cancer Patients
Malnutrition is common among cancer patients, often leading to muscle loss and decreased energy. The DGIM recommends regular assessments of nutritional status beginning at diagnosis, using validated instruments. Early nutritional counseling or therapy can significantly improve the patient’s strength and ability to endure treatment.
2. Barrett’s Esophagus Detection in Long-Term Reflux Patients
With approximately a quarter of the German population suffering from gastroesophageal reflux, careful monitoring is critical. When symptoms persist for years, the risk of Barrett’s esophagus—an early stage of esophageal cancer—rises. The DGIM advises at least one endoscopy for patients with chronic reflux to specifically assess for Barrett’s esophagus, while refraining from general screening due to insufficient data.
3. Avoiding Unnecessary Re-examinations for Irritable Bowel Syndrome
Patients with irritable bowel syndrome (IBS) experience significant quality-of-life declines due to symptoms like abdominal pain and bloating. Research indicates that the diagnosis of IBS remains stable in over 95% of cases over two to thirty years. Hence, without new clinical signs, repeated investigations are often unnecessary and can lead to additional stress for patients.
4. Targeting Exercise Therapy for Cardiovascular Risk
Exercise is not merely a wellness suggestion for patients at high cardiovascular risk. Studies highlight that tailored exercise programs can improve overall health outcomes significantly. Patients should receive specific movement prescriptions that consider their physical limitations and co-existing conditions.
5. Using the New CHA₂DS₂-VA Score for Stroke Risk in Atrial Fibrillation
Atrial fibrillation is the most common sustained arrhythmia, increasing stroke risks. For effective anticoagulation management, the DGIM recommends employing the new CHA₂DS₂-VA score, which helps healthcare providers evaluate stroke risk based on collected data, ensuring more personalized treatment decisions.
Conclusion
The recent recommendations from the DGIM highlight the pressing need for the right balance in medical interventions. The “Smart Decisions” initiative is more than an effort to cut costs; it enhances the quality of care while ensuring that resources are utilized effectively. As healthcare continues to evolve, physicians are encouraged to incorporate these guidelines into their practice, ensuring that each patient receives the most appropriate and personalized care.
For more detailed guidelines and access to all recommendations, visit www.klug-entscheiden.de.
